We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma (PICASSO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00718484
Recruitment Status : Unknown
Verified January 2014 by Ziopharm.
Recruitment status was:  Active, not recruiting
First Posted : July 18, 2008
Last Update Posted : January 30, 2014
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : April 2012
  Estimated Study Completion Date : April 2014